HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheng Yang Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

10/2023Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
9/2023Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients.
1/2023Genetic Profiling of Diffuse Large B-Cell Lymphoma: A Comparison Between Double-Expressor Lymphoma and Non-Double-Expressor Lymphoma.
1/2023Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018).
5/2022Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
11/2021The pretreatment platelet count predicts survival outcomes of diffuse large B-cell lymphoma: An analysis of 1007 patients in the rituximab era.
1/2020Prognostic Nomogram and Predictive Factors in Refractory or Relapsed Diffuse Large B-Cell Lymphoma Patients Failing Front-Line R-CHOP Regimens.
1/2020Genomic Alterations and MYD88MUT Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib.
12/2018Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure.
10/2015Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheng Yang Research Topics

Disease

99Neoplasms (Cancer)
04/2024 - 10/2002
27Infections
03/2024 - 02/2005
22Stomach Neoplasms (Stomach Cancer)
12/2023 - 07/2011
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 01/2012
18Lung Neoplasms (Lung Cancer)
03/2021 - 03/2003
16Lymphoma (Lymphomas)
02/2024 - 01/2012
15Neoplasm Metastasis (Metastasis)
04/2024 - 01/2012
14Carcinogenesis
04/2024 - 01/2006
13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2023 - 05/2012
13Adenocarcinoma of Lung
02/2023 - 10/2013
11Inflammation (Inflammations)
02/2024 - 02/2013
10Disease Progression
01/2023 - 11/2012
10Neutropenia
11/2020 - 04/2006
8Breast Neoplasms (Breast Cancer)
01/2016 - 10/2011
7Periodontitis
02/2024 - 12/2022
7Nasopharyngeal Carcinoma
01/2023 - 02/2013
6Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 09/2011
6Carcinoma (Carcinomatosis)
02/2024 - 11/2017
6Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2017 - 09/2005
5Demyelinating Diseases (Demyelinating Disease)
04/2024 - 01/2023
5Hepatocellular Carcinoma (Hepatoma)
04/2023 - 03/2016
5Stroke (Strokes)
01/2022 - 10/2002
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2020 - 06/2009
5Brain Neoplasms (Brain Tumor)
03/2020 - 09/2015
5Thrombocytopenia (Thrombopenia)
01/2018 - 10/2009
4Osteoporosis
04/2024 - 08/2016
4COVID-19
03/2024 - 01/2020
4Fibrosis (Cirrhosis)
01/2024 - 01/2022
4Aortic Dissection
08/2023 - 06/2010
4Pain (Aches)
01/2023 - 01/2005
4Type 2 Diabetes Mellitus (MODY)
06/2022 - 04/2013
4Insulin Resistance
06/2022 - 05/2012
4Hypertension (High Blood Pressure)
02/2022 - 05/2013
4Colonic Neoplasms (Colon Cancer)
01/2022 - 03/2016
4Anemia
07/2021 - 02/2016
4Adenocarcinoma
10/2019 - 10/2013
4Lymphatic Metastasis
10/2017 - 01/2012
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2017 - 03/2013
4B-Cell Lymphoma (Lymphoma, B Cell)
09/2015 - 08/2009
3Multiple Sclerosis
04/2024 - 05/2023
3Lung Injury
02/2024 - 10/2022
3Chronic Obstructive Pulmonary Disease (COPD)
02/2024 - 01/2022
3Bone Resorption
02/2024 - 10/2019
3Hemorrhage
01/2024 - 05/2019
3Ischemic Stroke
12/2023 - 10/2019
3T-Cell Lymphoma (Lymphoma, T Cell)
10/2023 - 01/2018
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2023 - 11/2012
3Neuroinflammatory Diseases
09/2023 - 01/2021
3Wounds and Injuries (Trauma)
01/2023 - 03/2005

Drug/Important Bio-Agent (IBA)

33Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2012
30Proteins (Proteins, Gene)FDA Link
02/2024 - 10/2002
21MicroRNAs (MicroRNA)IBA
12/2022 - 02/2013
15Long Noncoding RNAIBA
11/2023 - 01/2014
14Rituximab (Mabthera)FDA Link
10/2023 - 08/2009
13RNA (Ribonucleic Acid)IBA
04/2024 - 05/2013
10Messenger RNA (mRNA)IBA
01/2023 - 10/2014
9ErbB Receptors (EGF Receptor)IBA
01/2019 - 09/2011
8PlatinumIBA
09/2022 - 10/2013
8Cisplatin (Platino)FDA LinkGeneric
01/2022 - 09/2015
8GemcitabineFDA Link
11/2019 - 03/2013
7Transcription Factors (Transcription Factor)IBA
04/2024 - 01/2018
7Therapeutic UsesIBA
02/2024 - 03/2003
7Dexamethasone (Maxidex)FDA LinkGeneric
12/2023 - 07/2015
7Guanosine Diphosphate (GDP)IBA
11/2019 - 03/2013
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 07/2011
6CytokinesIBA
03/2024 - 10/2015
6Polystyrenes (Polystyrene)IBA
02/2024 - 10/2022
6DNA (Deoxyribonucleic Acid)IBA
01/2023 - 08/2009
6Tyrosine Kinase InhibitorsIBA
01/2019 - 10/2013
5Antiviral Agents (Antivirals)IBA
04/2024 - 01/2022
5L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2024 - 08/2014
56-methyladenineIBA
12/2023 - 01/2020
5N-methyladenosineIBA
11/2023 - 01/2020
5Monoclonal AntibodiesIBA
09/2023 - 09/2011
5SurvivinIBA
04/2023 - 01/2012
4Immunoglobulin G (IgG)IBA
04/2024 - 01/2020
4Interleukin-6 (Interleukin 6)IBA
03/2024 - 02/2013
4Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 07/2016
4Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 02/2013
4Indicators and Reagents (Reagents)IBA
11/2023 - 12/2014
4Doxorubicin (Adriamycin)FDA LinkGeneric
04/2023 - 08/2014
4apatinibIBA
09/2022 - 01/2017
4EnzymesIBA
02/2022 - 01/2020
4icotinibIBA
12/2017 - 01/2016
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2012 - 04/2006
3oxidized low density lipoproteinIBA
04/2024 - 01/2021
3Immune Checkpoint InhibitorsIBA
02/2024 - 01/2021
3SiliconIBA
12/2023 - 05/2014
3VaccinesIBA
12/2023 - 01/2018
3Oxidoreductases (Dehydrogenase)IBA
11/2023 - 04/2013
3AntioxidantsIBA
10/2023 - 10/2002

Therapy/Procedure

48Drug Therapy (Chemotherapy)
11/2023 - 04/2006
42Therapeutics
04/2024 - 03/2003
6Radiotherapy
08/2023 - 09/2015
5Ligation
02/2024 - 01/2023
4Immunotherapy
02/2024 - 01/2022
4Stem Cell Transplantation
04/2022 - 09/2005
4Transplantation
01/2021 - 03/2005
4Hematopoietic Stem Cell Transplantation
10/2017 - 06/2009
3VAP-cyclo protocol
01/2023 - 06/2012